| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.7104 | 
      | Human Intestinal Absorption | HIA+ | 0.9966 | 
      | Caco-2 Permeability | Caco2+ | 0.5662 | 
      | P-glycoprotein Substrate | Non-substrate | 0.8092 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.8094 | 
                                                     | Non-inhibitor | 0.9107 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.8348 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.6102 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.7253 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8819 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.6651 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.9045 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9070 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9230 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.9026 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.8383 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.5977 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9056 | 
                                                                    | Non-inhibitor | 0.7284 | 
      | AMES Toxicity | Non AMES toxic | 0.6607 | 
      | Carcinogens | Non-carcinogens | 0.8743 | 
      | Fish Toxicity | Low FHMT | 0.6767 | 
      | Tetrahymena Pyriformis Toxicity | Low TPT | 0.5426 | 
      | Honey Bee Toxicity | Low HBT | 0.7710 | 
      | Biodegradation | Not ready biodegradable | 1.0000 | 
      | Acute Oral Toxicity | IV | 0.6233 | 
      | Carcinogenicity (Three-class) | Non-required | 0.5163 |